Skip to content

Homoeopathy as adjuvant in management of Covid-19 infection

Effect of adjuvant homoeopathy with standard treatment protocol in management of covid-19: a randomised, open label, placebo controlled, parallel group study

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/024969
Enrollment
100
Registered
2020-05-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Homoeopathic medicine: Homoeopathic medicines will be given to this group patients as an add-on to standard treatmet. Following Individualization medicines will be selected keeping in v

Sponsors

Naiminath Homoeopathic Medical College Hospital and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: o Symptomatic RT-PCR confirmed cases of Covid-19 infection. o Both sexes o Age between 18 years to 80 years and o Willing to give signed written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients requiring ventilatory support 2. Patients with compromised immunity 3. Severe heart, lung, kidney, brain, blood diseases or other important systemic diseases 4. Subjects unable to complete the study, or not suitable for the study by researchers. 5. Women during pregnancy 6. Lactating mothers

Design outcomes

Primary

MeasureTime frame
Clinical outcome in terms of recovery of patient or requirement of life support (ventilator)/ death.Timepoint: Ever 24 hr.

Secondary

MeasureTime frame
i. Time to progression to critical stage ii. Time to fever clearance iii. Time to resolution of pneumonia iv. Change in severity of symptoms as per clinical syndromes associated with COVID - 19 infection. v. Time to recovery in terms of 2 negative test for Covid-19 vi. Period of hospital stay vii. Requirement of conventional medication till clinical improvement Timepoint: Ever 24 hr.

Countries

India

Contacts

Public ContactDr Anil Khurana

CCRH

drdnayak@gmail.com09873404012

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026